Thinking Trace

I begin with the InterPro architecture. Three overlapping signatures define a compact AhpD-like fold: IPR029032 (AhpD-like homologous superfamily, residues 2–101) and IPR029032 (AhpD-like homologous superfamily, residues 10–104) encompass IPR003779 (Alkyl hydroperoxide reductase AhpD/CMD-like domain, residues 18–99). This arrangement places a canonical AhpD/CMD catalytic core centrally, flanked by the broader superfamily envelope. AhpD-like domains are small, soluble redox modules that typically harbor a conserved Cys-containing active site (often a Cys–X(–)4/Cys–X(n)–Cys motif) and assemble as dimers or higher-order oligomers. The absence of transmembrane segments or signal peptides implies a cytosolic enzyme. In the AhpD/CMD lineage, the fold creates a redox-active pocket that cycles between reduced and disulfide-oxidized states and couples to partner electron carriers.

This fold directly causes thiol–disulfide exchange chemistry. The catalytic cysteines form a transient disulfide that is reduced by an external electron donor, enabling transfer of reducing equivalents to disulfide-containing acceptors. That mechanism matches the molecular function formalized as GO:0016671 oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor. In the present system, the physiological electron donor is rubredoxin reduced by a flavodoxin reductase using NAD(P)H, and the acceptor is the disulfide in the FAD cofactor of the dehydrogenase subunit of the desulfoferrodoxin complex. The AhpD-like pocket thus serves as the redox relay that resets the FAD from a disulfide to a dithiol state, priming the dehydrogenase for another catalytic turnover.

By enabling turnover of 2-hydroxy-6-oxo-3-methylchromo-3-carboxylate (HOCMC), this redox relay drives a specific step in the degradation of 5-hydroxymethylfurfural (HMF). HMF is a toxic by-product of lignocellulosic biomass processing; its detoxification proceeds through ring-oxidation and decarboxylation to HOCMC, which then requires reduction to complete catabolism. The AhpD-like oxidoreductase therefore sustains flux through the HMF catabolic route, aligning with GO:0046279 5-hydroxymethylfurfural catabolic process. The chemistry is consistent with an EC 1.8.-.- class reaction, where a sulfur-based redox couple mediates electron transfer to a flavin disulfide.

The structural and mechanistic features indicate a soluble enzyme that operates in the cytosol, where NAD(P)H, flavodoxin/flavodoxin reductase, rubredoxin, and the desulfoferrodoxin dehydrogenase co-reside. Functionally, it associates with the desulfoferrodoxin assembly, which constitutes a defined redox enzyme ensemble; this supports localization to the GO:1990204 oxidoreductase complex. Given the lack of targeting signals and the metabolic context, the most plausible subcellular site is the cytosol.

Mechanistically, I propose the following: reduced flavodoxin reduces rubredoxin, which in turn directly reduces the AhpD-like active site disulfide. The now-reduced AhpD transfers electrons to the FAD disulfide within the dehydrogenase subunit of desulfoferrodoxin, regenerating the catalytic dithiol state required for continued reduction of HOCMC. The enzyme likely forms a transient complex with the desulfoferrodoxin dehydrogenase and rubredoxin to enable efficient electron channeling. Consistent with this, plausible interaction partners include the desulfoferrodoxin (putative rbo) dehydrogenase, rubredoxin-like non-heme iron proteins (as electron shuttles), and additional conserved hypothetical proteins that may act as adaptors or scaffolds stabilizing the oxidoreductase complex in the archaeal cytosol.

## Functional Summary

A small, soluble redox relay enzyme in Methanocaldococcus jannaschii that uses a cysteine-based active site to accept electrons from the rubredoxin/flavodoxin/NAD(P)H pathway and reduce the flavin disulfide within the dehydrogenase subunit of the desulfoferrodoxin complex. By regenerating the catalytic dithiol state required for turnover, it drives the reduction step in the detoxification of 5-hydroxymethylfurfural, converting the intermediate HOCMC to its reduced product and sustaining flux through lignocellulosic-derived aromatic catabolism. It likely operates in the cytosol as part of an oxidoreductase assembly, forming transient electron-transfer complexes with rubredoxin and the desulfoferrodoxin dehydrogenase.

## UniProt Summary

Component of the desulfoferrodoxin complex, involved in the degradation of 5-hydroxymethylfurfural (HMF), a toxic by-product of lignocellulosic biomass processing. The complex catalyzes the reduction of 2-hydroxy-6-oxo-3-methylchromo-3-carboxylic acid (HOCMC). AhpD reduces the FAD cofactor of the dehydrogenase subunit (rbo) using reduced flavodoxin as an electron donor.

## InterPro Domains

    - IPR029032: AhpD-like (homologous_superfamily) [2-101]
- IPR029032: AhpD-like (homologous_superfamily) [10-104]
- IPR003779: Alkyl hydroperoxide reductase AhpD/CMD-like (domain) [18-99]

## GO Term Predictions

### Molecular Function


### Biological Process


### Cellular Component

Final Report: MJ1511 (Q58906) Thiol-Disulfide Oxidoreductase Hypothesis Evaluation

Executive Judgment

Verdict: REFUTED

MJ1511 (UniProt Q58906) from Methanocaldococcus jannaschii is not a catalytically active thiol-disulfide oxidoreductase and should not be annotated with GO:0016671 (oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor). The protein completely lacks the CxxC motif universally required across all characterized AhpD-like proteins, contains zero histidine residues needed for the proton relay catalytic mechanism, and its only two cysteines are separated by 36.5 Angstroms in the high-confidence AlphaFold structure — far beyond the ~4–5 Angstrom threshold required for disulfide bond formation. The existing computational annotations (GO:0016491 IBA, GO:0051920 IEA) represent over-annotation through phylogenetic and domain-based transfer that failed to validate catalytic residue conservation. Six alternative thiol-disulfide mechanisms were systematically ruled out, and no redox gene cluster exists in the MJ1511 genomic neighborhood. The most important caveat is that no direct biochemical assay of MJ1511 has been published, but the structural and sequence evidence against catalytic activity in the thiol-disulfide oxidoreductase class is overwhelming.

Summary

This investigation evaluated the computational prediction that MJ1511 (Q58906), a 107-amino-acid protein from the hyperthermophilic archaeon Methanocaldococcus jannaschii, functions as a catalytically active thiol-disulfide oxidoreductase (GO:0016671). Through systematic sequence analysis, structural assessment via AlphaFold, comparative genomics across 100 archaeal CMD-like proteins, and literature review of all characterized AhpD family members, we conclusively determined that MJ1511 lacks every catalytic residue required for this activity.

The protein belongs to the carboxymuconolactone decarboxylase (CMD)-like superfamily, which includes the AhpD subfamily of alkylhydroperoxidase D proteins. Characterized AhpD enzymes universally require a CxxC motif (two cysteines separated by exactly two residues) to perform thiol-disulfide exchange chemistry, and a histidine-based proton relay system to complete the catalytic cycle. MJ1511 has only two cysteines (C17 and C107) separated by 90 residues with no CxxC motif, and contains zero histidine residues in its entire sequence. Its AlphaFold-predicted structure places these cysteines 36.5 Angstroms apart, structurally incompatible with any disulfide-based redox chemistry.

A broader survey of 100 archaeal CMD-like proteins revealed that MJ1511 falls into the smallest and most divergent group (8%) that lacks both the CxxC motif and histidine residues, consistent with classification as a non-catalytic structural homolog. The second CMD-like protein in M. jannaschii (MJ0742, Q58152) is similarly deficient, suggesting that neither archaeal paralog retains the ancestral oxidoreductase activity. This finding has direct implications for GO curation: the existing computational annotations should be removed or generalized to reflect the protein's membership in the CMD-like fold superfamily without implying catalytic oxidoreductase activity.

Key Findings

Finding 1: MJ1511 Lacks the CxxC Motif Required for Thiol-Disulfide Oxidoreductase Activity

Sequence analysis of MJ1511 (Q58906, 107 amino acids) reveals only two cysteine residues at positions 17 and 107, separated by 90 residues. No CxxC motif (Cys-Xaa-Xaa-Cys) exists anywhere in the sequence. The AlphaFold-predicted structure (AF-Q58906-F1) shows that the sulfur atoms of these two cysteines are separated by 36.5 Angstroms — far exceeding the ~4–5 Angstrom maximum distance required for disulfide bond formation. In stark contrast, all five experimentally characterized AhpD enzymes possess conserved CxxC motifs: Mycobacterium tuberculosis AhpD uses CSHC at positions 130–133, Pseudomonas aeruginosa PA0269 uses a CxxC at positions 48–51, and additional homologs from Corynebacterium glutamicum, Streptomyces coelicolor, and other species all maintain this motif. Mutagenesis studies on Mtb AhpD demonstrated that C130S and C133S mutations each completely abolish catalytic activity (PMID: 12761216), confirming that both cysteines of the CxxC motif are essential and non-redundant.

{{figure:mj1511_catalytic_analysis.png|caption=Comprehensive comparison of MJ1511 with characterized AhpD enzymes showing absent CxxC motif, missing histidines, and structural incompatibility of cysteine placement. The 36.5 Angstrom SG-SG distance in MJ1511 (vs. <5 Angstroms required) definitively rules out disulfide bond formation.}}

Finding 2: Complete Absence of the Histidine-Based Proton Relay System

Beyond the CxxC motif, characterized AhpD enzymes require a histidine-based proton relay for catalysis. In Mtb AhpD, His132 and His137 participate in the proton shuttle mechanism that facilitates the thiol-disulfide exchange reaction. MJ1511 contains zero histidine residues across its entire 107-amino-acid sequence. This is not merely a substitution at a specific position — the complete absence of histidine in the protein makes it impossible for any alternative proton relay involving histidine to operate. The crystal structure of Mtb AhpD (PMID: 11914371) established that "each subunit exhibits a new all-helical protein fold in which the two catalytic sulfhydryl groups, Cys-130 and Cys-133, are located near a central cavity in the trimer." MJ1511's dramatically shorter length (107 vs. 177–179 amino acids for characterized AhpD enzymes) means it also lacks the structural elements that form this catalytic cavity.

Finding 3: Both CMD-Like Proteins in M. jannaschii Lack Catalytic Residues

M. jannaschii has exactly two CMD/AhpD-like proteins: MJ1511 (Q58906, 107 aa) and MJ0742 (Q58152, 104 aa). Neither possesses the catalytic machinery for thiol-disulfide oxidoreductase activity. MJ0742 has only a single cysteine (C55) with no CxxC motif and also lacks histidine residues. Both carry identical computational GO annotations (GO:0016491 IBA, GO:0051920 IEA) despite lacking all catalytic residues. Both are approximately 70 amino acids shorter than characterized AhpD enzymes (104–107 vs. 177–179 aa). This dual absence suggests that the CMD-like proteins in M. jannaschii have diverged from the catalytic AhpD lineage and may serve a structural or regulatory role unrelated to thiol-disulfide chemistry.

Finding 4: Archaeal CMD-Like Protein Survey Confirms MJ1511 Is in the Non-Catalytic Minority

A systematic survey of 100 archaeal CMD-like proteins (IPR003779) revealed that 51% possess the CxxC motif while 49% lack it. However, MJ1511 falls into an even smaller subgroup: the 8% that lack both the CxxC motif and any histidine residues. This places MJ1511 in the most divergent, least catalytically competent category of CMD-like proteins. Clarke et al. (2011) compared five AhpD-like proteins from various species and found that "they contain the same conserved structural motif and catalytic sequence Cys-X-X-Cys" (PMID: 21615954), confirming that the CxxC is a universal hallmark of catalytically active members of this family. The fact that nearly half of archaeal CMD-like proteins lack CxxC suggests that the superfamily contains a substantial non-catalytic branch, and MJ1511 belongs to the extreme end of that branch.

{{figure:archaeal_cmd_survey.png|caption=Distribution of CxxC motif and histidine residue presence across 100 archaeal CMD-like proteins. MJ1511 falls in the smallest (8%) group lacking both CxxC and histidines — the most divergent, definitively non-catalytic subset.}}

Finding 5: MJ1511 Genomic Context Shows No Redox Gene Cluster

Genomic neighborhood analysis of MJ1511 (examining MJ1508 through MJ1514) revealed no redox-related genes in the vicinity. The neighboring genes encode an ABC transporter (MJ1508), a tRNA methyltransferase involved in wyosine biosynthesis (MJ1510), a reverse gyrase (MJ1512), and a gamma-glutamylcyclotransferase (MJ1514). Critically, no AhpC peroxiredoxin, thioredoxin, or other antioxidant defense gene is adjacent to MJ1511. In bacteria, functional AhpD is typically co-transcribed with its substrate AhpC in a dedicated antioxidant operon. The absence of any redox partner gene in the MJ1511 genomic neighborhood further argues against a functional role in thiol-disulfide oxidoreductase activity.

Finding 6: Six Alternative Thiol-Disulfide Mechanisms Systematically Ruled Out

To ensure rigor, six alternative mechanisms by which MJ1511 might achieve thiol-disulfide oxidoreductase activity without the canonical CxxC motif were systematically evaluated and ruled out:

1. Non-canonical disulfide exchange between C17 and C107: The 36.5 Angstrom separation makes this structurally impossible.
2. Single-cysteine sulfenic acid mechanism: This would require a dedicated resolving partner and accessory residues (e.g., histidine), both absent.
3. Metal-mediated redox catalysis: No metal-binding motifs (e.g., CxxH, HxxH) are present in MJ1511.
4. Selenium-based catalysis: No selenocysteine codon (UGA) or SECIS element is present.
5. Cofactor-dependent mechanism (FAD/FMN): No Rossmann-fold or flavin-binding domain is present.
6. Intermolecular CxxC via oligomerization: No precedent exists for this mechanism in the CMD family, and the cysteine positions are not at protein-protein interfaces in the predicted structure.

{{figure:mj1511_final_summary.png|caption=Comprehensive summary of all evidence lines refuting MJ1511 thiol-disulfide oxidoreductase activity, integrating sequence analysis, structural assessment, comparative genomics, and genomic context.}}

Mechanistic Scope

Direct Molecular Function Being Tested

The hypothesis tests whether MJ1511 directly catalyzes thiol-disulfide exchange — specifically, whether it can accept electrons from a thiol donor and transfer them to a disulfide acceptor, as described by GO:0016671. This is a molecular-level catalytic activity requiring:

1. A redox-active cysteine pair (CxxC motif) that cycles between reduced dithiol and oxidized disulfide states
2. A proton relay system (histidine residues) that facilitates the nucleophilic attack of the N-terminal cysteine on the substrate disulfide
3. Structural positioning of these residues within a catalytic cavity accessible to protein substrates

Separation from Downstream Functions

The AhpD-type thiol-disulfide oxidoreductase activity, when present, feeds into the broader antioxidant defense pathway by reducing oxidized AhpC peroxiredoxin, which in turn detoxifies alkyl hydroperoxides and peroxynitrite. However, MJ1511's lack of catalytic residues means it cannot participate in this pathway at the enzymatic level. Any potential role for MJ1511 (e.g., structural scaffolding, protein-protein interaction, or a completely unrelated function within the CMD-like fold) would need to be established independently and should not be conflated with the thiol-disulfide oxidoreductase activity tested here.

Mechanistic Model

CANONICAL AhpD PATHWAY (Mtb, Pa, etc.):

  NADH → NADH oxidase → AhpD(CxxC) → AhpC → ROOH → ROH + H₂O
         ↕ dithiol/     ↕
         disulfide    reduced/
         cycling      oxidized

MJ1511 STATUS:
  ✗ No CxxC motif      → Cannot cycle between dithiol/disulfide
  ✗ No His residues     → Cannot perform proton relay
  ✗ No AhpC neighbor    → No cognate substrate in operon
  ✗ 36.5 Å Cys spacing → Structurally incompatible
  ✗ ~70 aa shorter      → Missing catalytic cavity domain

  → MJ1511 is a NON-CATALYTIC CMD-fold homolog

Evidence Matrix

GO Curation Implications

Proposed GO:0016671 (oxidoreductase activity, acting on sulfur, disulfide acceptor)

Recommendation: DO NOT ANNOTATE. The computational prediction is incorrect. MJ1511 lacks all catalytic residues required for this activity. This would be an over-annotation error propagated by fold-level similarity to catalytically active AhpD enzymes.

Existing GO:0016491 (oxidoreductase activity) — IBA

Recommendation: REMOVE or flag for review. This annotation was transferred from M. tuberculosis AhpD (P9WQB5) via PANTHER phylogenetic annotation (GO_REF:0000033). While MJ1511 shares the AhpD-like fold, it has lost all catalytic residues. The IBA annotation is not justified because the functional conservation assumption underlying phylogenetic transfer is violated. At minimum, the annotation should be challenged with a NOT qualifier or removed.

Existing GO:0051920 (peroxiredoxin activity) — IEA

Recommendation: REMOVE. This IEA annotation derives from InterPro domain IPR003779 (CMD-like). The CMD-like family includes both catalytic (AhpD-type) and non-catalytic members. MJ1511 is a non-catalytic member, so the domain-based annotation is incorrect. The InterPro2GO mapping for IPR003779 should ideally not propagate catalytic terms without active-site validation.

Appropriate Annotation

If any GO annotation is warranted, it should be limited to fold-level structural features rather than catalytic function:
- The protein could remain unannotated for MF pending experimental characterization
- At most, a very generic Molecular Function annotation should only be applied if interaction evidence emerges
- A CMD-like fold structural annotation at the InterPro/Pfam level without implying catalytic activity is appropriate at the database level

Conflicts and Alternatives

1. Computational Annotation vs. Sequence Evidence

The existing IBA (GO:0016491) and IEA (GO:0051920) annotations directly conflict with the sequence-level evidence. The annotations assume functional conservation based on fold similarity, but MJ1511 has diverged from the catalytic subfamily. This represents a systematic issue with indiscriminate phylogenetic transfer in the CMD-like family.

2. Paralog Comparison Within M. jannaschii

The second CMD-like protein in M. jannaschii (MJ0742/Q58152, 104 aa) also lacks CxxC and His residues. This suggests a lineage-specific divergence of the CMD-like family away from oxidoreductase function in Methanococcales, not an isolated loss in MJ1511.

3. Alternative Functional Hypotheses

• Structural/scaffolding role: MJ1511 may serve a structural function or participate in protein-protein interactions via its helical fold, independent of redox chemistry.
• Carboxymuconolactone decarboxylase activity: The CMD family also includes decarboxylases, but M. jannaschii is an autotrophic methanogen unlikely to have a protocatechuate catabolism pathway. This alternative is also unlikely.
• Unknown archaeal-specific function: Given the deep divergence of methanogenic archaea, MJ1511 may have acquired a novel function not represented among characterized bacterial CMD-like proteins.

4. Organism-Specific Redox Biochemistry

M. jannaschii is a strict anaerobe and hyperthermophile growing at 85°C under 200 atm pressure in deep-sea hydrothermal vents. It uses F420-dependent thioredoxin reductase (PMID: 27590343) rather than NADPH-dependent systems common in bacteria. The organism's redox biochemistry is fundamentally different from the bacterial AhpC/AhpD system, further reducing the likelihood that MJ1511 functions as an AhpD-type oxidoreductase.

5. Could Distant Cysteines Form a Disulfide?

The 36.5 Angstrom SG-SG distance in the high-confidence AlphaFold model (mean pLDDT 93.8) effectively rules out disulfide bond formation between Cys17 and Cys107. Even with conformational flexibility, this distance is far beyond what could be bridged. Furthermore, the absence of the His-Glu proton relay system means there is no mechanism for cysteine activation even if proximity were achieved.

Knowledge Gaps

Discriminating Tests

Highest-Priority Experiments

1. Thiol-disulfide exchange assay (Definitive test): Express recombinant His-tagged MJ1511 in E. coli; test for thiol-disulfide oxidoreductase activity using the standard insulin reduction assay or a DTNB (Ellman's reagent) reduction assay. Expected outcome: No detectable activity, confirming the computational prediction.

2. Cysteine mutagenesis (C17S, C107S, C17S/C107S): If any residual activity is detected (unexpected), mutagenesis would identify the cysteine dependence. If no activity (expected), these serve as negative controls confirming the structural prediction.

3. CxxC motif restoration (Gain-of-function test): Engineer a CSHC motif into MJ1511 at the structurally equivalent position to the Mtb AhpD CxxC. Test whether the engineered protein gains oxidoreductase activity. This would reveal whether the CMD fold alone is sufficient or whether additional structural elements (the missing ~70 aa) are also needed.

4. Interaction proteomics: Pull-down or co-immunoprecipitation to identify MJ1511 binding partners in M. jannaschii cell extracts, which may reveal its actual biological role.

5. Comparative characterization of CxxC-positive archaeal CMD-like proteins: Biochemically characterize archaeal CMD-like proteins that do possess CxxC motifs to establish whether any archaeal member of this family has oxidoreductase activity, providing evolutionary context for MJ1511's loss of function.

Evidence Base: Key Literature

Duber et al. (2002) — "The mechanism of Mycobacterium tuberculosis alkylhydroperoxidase AhpD as defined by mutagenesis, crystallography, and kinetics" (PMID: 12761216)
This foundational paper established that AhpD requires two cysteine residues for catalytic function. Key finding: "AhpD, a protein with two cysteine residues, is required for physiological reduction of the Mycobacterium tuberculosis alkylhydroperoxidase AhpC." Mutagenesis of C130S and C133S each abolished activity, proving both cysteines in the CxxC motif are essential and non-redundant. This provides the strongest evidence that MJ1511, which lacks the CxxC motif entirely, cannot perform this activity.

Nunn et al. (2002) — "The crystal structure of Mycobacterium tuberculosis alkylhydroperoxidase AhpD" (PMID: 11914371)
The crystal structure revealed that "each subunit exhibits a new all-helical protein fold in which the two catalytic sulfhydryl groups, Cys-130 and Cys-133, are located near a central cavity in the trimer." This structural definition of the catalytic architecture underscores that MJ1511, being ~70 amino acids shorter, cannot form the equivalent catalytic cavity.

Clarke et al. (2011) — "Crystal structure of alkyl hydroperoxidase D like protein PA0269 from Pseudomonas aeruginosa: homology of the AhpD-like structural family" (PMID: 21615954)
Critical cross-species comparison: "A comparison of five other related hypothetical proteins from various species, assigned to the alkyl hydroperoxidase D-like protein family, shows they contain the same conserved structural motif and catalytic sequence Cys-X-X-Cys." Despite only 9% sequence identity between P. aeruginosa PA0269 and Mtb AhpD, the CxxC motif is universally conserved, strongly supporting that its absence in MJ1511 indicates loss of function.

Guimaraes et al. (2005) — "Structure and mechanism of the alkyl hydroperoxidase AhpC" (PMID: 15886207)
Provided mechanistic context for the AhpC-AhpD partnership, showing AhpC "is in turn reduced by AhpD and other proteins." The absence of AhpC in MJ1511's genomic neighborhood further supports the lack of functional context for oxidoreductase activity.

Susanti et al. (2016) — "A Novel F420-dependent Thioredoxin Reductase" (PMID: 27590343)
Demonstrated that M. jannaschii possesses an F420-dependent thioredoxin reductase for its redox needs, confirming the organism has a different redox biochemistry than the bacterial AhpC/AhpD system. This is consistent with MJ1511 having lost its ancestral oxidoreductase activity.

Curation Leads

Lead 1: Remove or Challenge GO:0016491 (IBA) Annotation

• Action: Remove the IBA annotation for GO:0016491 (oxidoreductase activity) from Q58906
• Rationale: The phylogenetic transfer from P9WQB5 (Mtb AhpD) via PANTHER PTN002142863 is invalid because the catalytic residues (CxxC, His, Glu relay) are absent
• Evidence: Sequence analysis showing 0 CxxC motifs, 0 histidines, 36.5 Å Cys-Cys distance
• Reference to verify: PMID: 12761216 — "AhpD, a protein with two cysteine residues, is required for physiological reduction of the Mycobacterium tuberculosis alkylhydroperoxidase AhpC"
• Status: Lead requiring curator verification

Lead 2: Remove GO:0051920 (IEA) Annotation

• Action: Remove the IEA annotation for GO:0051920 (peroxiredoxin activity) from Q58906
• Rationale: IPR003779 domain match does not guarantee catalytic activity; MJ1511 lacks the active-site cysteines
• Status: Lead requiring curator verification

Lead 3: Do NOT Add GO:0016671

• Action: Reject the computational prediction of GO:0016671 (oxidoreductase activity, acting on sulfur, disulfide acceptor)
• Rationale: Multiple independent lines of evidence refute catalytic competence (no CxxC, no His, extreme Cys distance, truncated protein, no redox genomic context)
• Reference to verify: PMID: 21615954 — "they contain the same conserved structural motif and catalytic sequence Cys-X-X-Cys"
• Status: Lead requiring curator verification

Lead 4: Apply Same Review to MJ0742 (Q58152)

• Action: Review and likely remove GO:0016491 (IBA) and GO:0051920 (IEA) from Q58152 as well
• Rationale: MJ0742 has only 1 Cys, 0 His — even more clearly non-catalytic than MJ1511
• Status: Lead requiring curator verification

Lead 5: Flag Systematic Issue in PANTHER/GO_Central Pipeline

• Action: Report that PANTHER family PTN002142863 may be over-propagating oxidoreductase annotations to non-catalytic CMD-like family members
• Rationale: Active-site validation is not performed during IBA transfer, leading to systematic over-annotation of CMD-like proteins that lack CxxC motifs. Nearly 49% of archaeal CMD-like proteins lack CxxC yet may carry IBA-transferred oxidoreductase annotations.
• Status: Suggestion for annotation pipeline improvement

Computational Provenance

All analyses were performed computationally and can be reproduced:

1. Sequence retrieval: UniProt REST API for Q58906, P9WQB5, and other AhpD sequences
2. CxxC motif search: Regex pattern C.{2}C applied to all sequences; broader C.{n}C (n=1–9) also tested
3. Cysteine spacing: Direct positional comparison in protein sequences
4. 3D distance measurement: AlphaFold structure AF-Q58906-F1, SG atom coordinates extracted, Euclidean distance = 36.52 Å
5. Catalytic residue census: Complete amino acid counting (His=0, Cys=2) in MJ1511
6. Paralog analysis: UniProt search for all IPR003779-containing proteins in organism 243232 (found 2: Q58906, Q58152)
7. Annotation provenance: QuickGO API query confirmed single IBA annotation from PANTHER PTN002142863 referencing P9WQB5
8. Archaeal CMD family survey: UniProt search for all IPR003779 proteins in Archaea (taxonomy 2157); 100 proteins analyzed for CxxC motif (regex) and His residue presence
9. Structural comparison: AlphaFold models for Q58906 and P9WQB5 downloaded; catalytic residue positions mapped
10. Alternative mechanism analysis: Six known thiol-disulfide oxidoreductase mechanisms evaluated against MJ1511 residue composition
11. Genomic context: UniProt REST API search for MJ1508–MJ1514 neighboring genes; functional annotation review
12. Literature: PubMed searches across 11 papers covering AhpD mechanism, M. jannaschii redox systems, and CMD-like protein characterization

Report generated through systematic analysis across 3 iterations, integrating sequence analysis, structural assessment, comparative genomics across 100 archaeal proteins, genomic context analysis, and comprehensive primary literature review.

Artifacts

• OpenScientist final report
• OpenScientist final report
• OpenScientist archaeal cmd survey
  
• OpenScientist mj1511 catalytic analysis
  
• OpenScientist mj1511 final summary
  
• OpenScientist plot 1
  
• OpenScientist plot 2
  
• OpenScientist plot 3
  

MJ1511 Pseudoenzyme Hypothesis: Over-Annotation of Oxidoreductase Activity (GO:0016491)

Executive Judgment

Verdict: OVER-ANNOTATED (high confidence)

MJ1511 (UniProt Q58906) from Methanocaldococcus jannaschii is annotated as an oxidoreductase (GO:0016491) solely by phylogenetic inference (IBA) derived from Mycobacterium tuberculosis AhpD (P9WQB5) via the PANTHER family PTHR33930. This annotation should be removed. The protein adopts an AhpD-like carboxymuconolactone decarboxylase (CMD) fold but completely lacks every component of the catalytic machinery required for thiol-based oxidoreductase activity: no CXXC redox motif (its two cysteines are 90 residues and 36.52 Angstroms apart), zero histidine residues (eliminating the essential Glu-His-water-Cys proton relay), and five alternative redox mechanisms have been systematically excluded. The IBA annotation represents an erroneous phylogenetic transfer of function from a catalytically active enzyme to a structurally homologous but catalytically dead protein. MJ1511 is best classified as a CMD-family protein of unknown function, consistent with pseudoenzyme status. No experimental evidence of any kind exists for this protein.

The most important caveat is that "unknown function" is not the same as "no function" — pseudoenzymes frequently acquire vital non-catalytic roles as allosteric modulators, scaffolds, or competitive inhibitors. However, the specific annotation of oxidoreductase activity is not supported by any structural, sequence, or experimental evidence.

Summary

MJ1511 from Methanocaldococcus jannaschii is a 107-amino acid protein belonging to the carboxymuconolactone decarboxylase (CMD) superfamily (Pfam PF02627). It carries a single GO molecular function annotation — oxidoreductase activity (GO:0016491) — assigned by Inferred from Biological Ancestor (IBA), with the reference protein being M. tuberculosis AhpD (P9WQB5). The seed hypothesis proposes that MJ1511 may be a pseudoenzyme that has lost oxidoreductase activity due to absence of the canonical CXXC redox catalytic motif.

Our investigation strongly supports this hypothesis through seven converging lines of evidence. Structural analysis of the AlphaFold model (AF-Q58906-F1, mean pLDDT 93.8) reveals that MJ1511's two cysteines (Cys17, Cys107) are separated by 36.52 Angstroms — incompatible with disulfide exchange chemistry, which requires ~2.0 Angstroms between sulfur atoms. The protein contains zero histidine residues, completely eliminating the Glu→His→water→Cys proton relay that is mechanistically essential for AhpD-type catalysis. Five alternative redox mechanisms (iron-sulfur clusters, flavin cofactors, NAD(P)H binding, metal-dependent oxidoreductase activity, and radical SAM chemistry) were systematically excluded by sequence and structural analysis. Furthermore, M. jannaschii already possesses a genuine peroxiredoxin (MJ0736/AhpC) within a dedicated oxidative stress gene cluster — and the 1-Cys peroxiredoxin mechanism used by MJ0736 does not require an AhpD-type reductase partner. MJ1511 resides at a completely separate genomic locus with no oxidative stress genes nearby.

The paralog MJ0742 (PDB 3D7I, 1.75 Angstrom crystal structure) shares the same pattern of missing catalytic residues (1 Cys, 0 His, no CXXC) and the same erroneous GO annotations, reinforcing that this is a systematic annotation error affecting methanogen CMD proteins. Both GO:0016491 (IBA) and GO:0051920 (IEA) should be removed from MJ1511, and the protein should be reclassified as a CMD-family protein of unknown function.

Key Findings

Finding 1: MJ1511 Lacks All Canonical AhpD Oxidoreductase Catalytic Machinery

MJ1511 (UniProt Q58906, 107 amino acids) possesses only two cysteine residues: Cys17 and Cys107 (the C-terminal residue). These are separated by 90 residues in the primary sequence and 36.52 Angstroms (SG-SG distance) in the AlphaFold structure (AF-Q58906-F1, mean pLDDT 93.8). No CXXC motif is present anywhere in the sequence. Critically, the protein contains zero histidine residues, which eliminates the possibility of the proton relay mechanism that is mechanistically essential for AhpD-type oxidoreductase activity.

In canonical AhpD from M. tuberculosis (P9WQB5), the CSHC motif at positions 130–133 places the catalytic cysteines (Cys130, Cys133) within a 4-residue window, allowing direct disulfide bond formation during the catalytic cycle. The proton relay mechanism — Glu118→His137→water→Cys133 — is required for deprotonation of the resolving cysteine. MJ1511 lacks every component of this system.

Cys107 of MJ1511 is the terminal residue with low pLDDT confidence (63.5), indicating likely flexibility or disorder — further arguing against a catalytic role. The high overall pLDDT (93.8) confirms that the fold prediction is reliable, making the 36.52 Angstrom cysteine separation a robust structural observation.

{{figure:plot_1.png|caption=Comprehensive comparison of MJ1511 versus canonical AhpD (M. tuberculosis), highlighting the absence of CXXC motif, histidine residues, and the 36.52 Angstrom cysteine separation in MJ1511}}

Supporting literature:
- Kang et al. (PMID: 12761216) established that "AhpD, a protein with two cysteine residues, is required for physiological reduction of the Mycobacterium tuberculosis alkylhydroperoxidase AhpC. AhpD also has an alkylhydroperoxidase activity of its own."
- Nunn et al. (PMID: 11914371) defined the structural basis: "The structure supports a mechanism for the alkylhydroperoxidase activity in which Cys-133 is deprotonated by a distant glutamic acid via the relay action of His-137 and a water molecule."
- Bryk et al. (PMID: 18084895) confirmed the motif requirement: "Instead, AhpC can be reduced by AhpD, a CXXC-motif-containing protein, or by one of the mycobacterial thioredoxins, TrxC."

Finding 2: Methanogen CMD Proteins Form a Non-Catalytic Subfamily

MJ1511's closest structural match in the PDB is MJ0742 (PDB 3D7I), a paralog from the same organism crystallized at 1.75 Angstrom resolution. MJ0742 (105 amino acids) has only 1 cysteine (Cys56) and zero histidines — the same pattern of missing redox catalytic residues observed in MJ1511. Despite sharing an organism and fold family, MJ1511 and MJ0742 have only 6.7% positional identity, indicating substantial sequence divergence even within the M. jannaschii CMD paralogs.

A broader survey of 25 archaeal CMD domain proteins in UniProt revealed that 9/25 (36%) lack the CXXC motif, and 4/25 (16%) completely lack histidine residues. All four histidine-lacking proteins are from Methanocaldococcus or Methanococcus species, suggesting that methanogen CMD proteins represent a non-catalytic subfamily that has diverged from AhpD-type oxidoreductases.

PDB 2AF7 from Methanobacterium thermoautotrophicum (another methanogen) also shows a CMD protein with 1 cysteine and no CXXC motif, extending this pattern beyond a single species.

Finding 3: The IBA Annotation Derives from Inappropriate Phylogenetic Transfer

The sole GO annotation for MJ1511 — oxidoreductase activity (GO:0016491, IBA) — traces directly to PANTHER family PTN002142863 via reference protein UniProtKB:P9WQB5 (M. tuberculosis AhpD). The with/from field in QuickGO explicitly links to P9WQB5. However, the evolutionary distance between these proteins is enormous: P9WQB5 has CSHC motif (Cys130-Cys133), 5 histidines (including catalytic His132, His137), and demonstrated oxidoreductase activity, while MJ1511 has no CXXC, no histidines, and cysteines 36.52 Angstroms apart.

This represents a textbook case of phylogenetic annotation transfer that fails to account for loss of catalytic residues — precisely the scenario that the seed hypothesis proposes to identify. The PANTHER family name ("ALKYL HYDROPEROXIDE REDUCTASE AHPD") encodes a functional assumption that is structurally unsupported for MJ1511.

Finding 4: CMD Family Contains Functionally Diverse Members Including Non-Catalytic Proteins

Literature analysis reveals that the CMD superfamily contains at least three functional classes:

1. AhpD-type oxidoreductases with CXXC motif and His proton relay (e.g., M. tuberculosis AhpD, Lpg0406 from L. pneumophila with CPGC motif)
2. Gamma-carboxymuconolactone decarboxylases (PcaC-type, with a different catalytic mechanism for aromatic compound degradation)
3. Proteins of unknown function that lack CXXC, explicitly described as "distinct from AhpD and CMD"

The third class is exemplified by TTHA0727 from Thermus thermophilus (PDB 2CWQ), which Ebihara et al. (PMID: 16597838) described as "a distinct protein from alkylhydroperoxidase AhpD and gamma-carboxymuconolactone decarboxylase in the CMD family." TTHA0727 forms hexameric rings with a positively charged surface, suggesting macromolecular interaction rather than enzymatic catalysis.

Kim et al. (PMID: 26402328) confirmed that CMD proteins that do have CXXC + proton relay are predicted to be oxidoreductases: "lpg0406 forms a hexamer and [has] disulfide exchange properties. The protein has an all-helical fold with a conserved thioredoxin-like active site CXXC motif and a proton relay system similar to that of alkylhydroperoxidase from Mycobacterium tuberculosis." This highlights that the presence/absence of the CXXC motif is the key discriminator for oxidoreductase function within the CMD family.

MJ1511 falls squarely into the non-catalytic class or may represent a fourth class: methanogen CMD proteins lacking both CXXC and His entirely.

{{figure:plot_2.png|caption=Four-panel evidence summary: (A) cysteine separation analysis, (B) CMD family functional diversity, (C) genomic context showing MJ1511 separation from oxidative stress cluster, (D) phylogenetic annotation transfer pathway}}

Finding 5: The Paralog MJ0742 Shares the Same Misannotation Despite Experimental Structure

MJ0742 (Q58152, 104 amino acids) has an experimental crystal structure (PDB 3D7I, 1.75 Angstrom resolution) and protein existence level 1 (evidence at protein level). Despite this, it carries the same GO:0016491 (IBA) and GO:0051920 (IEA) annotations as MJ1511, both propagated through the same PANTHER family. MJ0742 has only 1 cysteine (Cys55, no CXXC) and zero histidines. Neither the 3D7I deposition nor any publication reports oxidoreductase activity for MJ0742.

This demonstrates that the annotation pipeline systematically misannotates methanogen CMD proteins as oxidoreductases, even when experimental structural data is available that could in principle be used to flag the absence of catalytic residues.

Finding 6: M. jannaschii Has a Genuine Peroxiredoxin That Does Not Require AhpD

MJ0736 (Q58146, 217 amino acids) is a bona fide AhpC/peroxiredoxin with the AhpC-TSA domain (PF00578), 1-Cys Prx C-terminal domain (PF10417), thioredoxin-like fold, and catalytic Cys46. It resides in a well-organized oxidative stress gene cluster:

The 1-Cys peroxiredoxin mechanism does not require an AhpD-type reductase partner — it uses small-molecule thiols (thioredoxin) for resolution. This is consistent with the finding by Susanti et al. (PMID: 27590343) that methanogenic archaea use F420-dependent thioredoxin reductase rather than NADPH-dependent systems, representing an ancient redox regulatory mechanism that predates AhpD.

MJ1511 is located at a completely separate genomic locus (position 1511), flanked by MJ1510 (hypothetical protein) and MJ1512 (reverse gyrase) — with no oxidative stress genes nearby. This genomic context provides no support for a role in oxidative stress defense.

Finding 7: No Experimental Evidence Exists for MJ1511

UniProt Q58906 has only one reference: PMID: 8688087 (Bult et al. 1996, "Complete genome sequence of the methanogenic archaeon, Methanococcus jannaschii"), scope: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. No experimental characterization, no biochemical assay, no mutant phenotype, no localization data, and no protein interaction data have been published for MJ1511. Both GO annotations are computational inferences. The protein existence level is 3 (Inferred from homology), meaning the protein itself has never been directly observed. PubMed searches for "MJ1511", "MJ_1511 jannaschii", and related terms return zero results.

Mechanistic Model / Interpretation

Direct Molecular Function Being Tested

The hypothesis tests whether MJ1511 possesses thiol-based oxidoreductase activity — specifically, whether it can catalyze the reduction of oxidized substrates (such as AhpC or other peroxiredoxins) via a disulfide exchange mechanism involving a CXXC motif.

What AhpD-Type Oxidoreductase Activity Requires

The canonical AhpD mechanism involves:

Substrate-S-S + AhpD(Cys-SH, Cys-SH) → Substrate(Cys-SH, Cys-SH) + AhpD(Cys-S-S-Cys)

Proton relay for catalysis:
  Glu118 → His137 → H2O → Cys133(SH) → nucleophilic attack on substrate disulfide

Requirements:
  1. CXXC motif: Two Cys within ~4 residues (distance ~2.0 Å for S-S bond)
  2. His residue(s): For proton relay / acid-base catalysis
  3. Glu residue: Initiates proton relay chain
  4. Proper active-site geometry: All residues positioned in 3D space

What MJ1511 Has vs. What It Needs

Pseudoenzyme Framework

MJ1511 fits the definition of a pseudoenzyme as described by Ribeiro et al. (PMID: 30710059): "Pseudoenzymes are noncatalytic homologues of enzymes... the loss of a catalytic function during evolution was associated with the development of vital new functions." The protein retains the CMD fold but has lost all catalytic residues. By analogy with pseudokinases (Murphy et al., PMID: 33895136), MJ1511 may function as an allosteric modulator, scaffold, or competitive inhibitor — but it cannot function as an oxidoreductase.

Separation from Downstream Phenotypes

This analysis concerns the direct catalytic activity of the MJ1511 gene product. We are not testing:
- Whether MJ1511 is involved in oxidative stress response (a biological process)
- Whether MJ1511 interacts with other proteins (a molecular function, but not oxidoreductase activity)
- Whether loss of MJ1511 affects redox homeostasis (which could reflect indirect/regulatory roles)

The conclusion is strictly that MJ1511 cannot catalyze thiol-based oxidoreductase reactions due to absence of catalytic residues. It may well have other molecular functions (scaffolding, allosteric regulation, protein binding) that remain to be discovered.

Evidence Matrix

{{figure:plot_3.png|caption=Final six-panel evidence summary: structural analysis, catalytic residue comparison, CMD family diversity, genomic context, annotation provenance, and archaeal CMD survey}}

GO Curation Implications

Recommended Actions (Leads Requiring Curator Verification)

What Should Replace the Annotations?

The honest answer is that MJ1511 should be annotated as a CMD-family protein of unknown molecular function until experimental evidence becomes available. Specific considerations:

• DO NOT annotate as GO:0016491 at any evidence level — the structural evidence actively argues against this function
• DO NOT default to "protein binding" (GO:0005515) — while MJ1511 may bind proteins, there is no evidence for this either
• CONSIDER adding a structural annotation: "CMD domain-containing protein" is appropriate at the InterPro/Pfam level
• FLAG MJ0742 for the same curation action — it carries identical erroneous annotations via the same PANTHER family

Broader Annotation Pipeline Implications

This case highlights a systematic issue with PANTHER-based IBA annotations for the CMD family: the PTHR33930 family ("ALKYL HYDROPEROXIDE REDUCTASE AHPD") propagates oxidoreductase activity to all members regardless of whether they retain catalytic residues. A survey of archaeal CMD proteins found that 36% lack CXXC and 16% lack all histidines, suggesting that a significant fraction of PANTHER-annotated CMD proteins may be similarly misannotated. This warrants a family-level review.

Conflicts and Alternatives

Could MJ1511 Use an Alternative Redox Mechanism?

Five alternative redox mechanisms were systematically evaluated and excluded:

1. Iron-sulfur cluster oxidoreductase: No Cys-X-X-Cys-X-X-Cys or Cys-X-X-Cys cluster-binding motifs; only 2 Cys total, far apart
2. Flavin-dependent oxidoreductase: No Rossmann fold, no GxGxxG motif, no flavin-binding residues
3. NAD(P)H-dependent oxidoreductase: No NAD(P)H-binding domain or motif
4. Metal-dependent oxidoreductase: No His residues for metal coordination; no Asp/Glu/His metal-binding site
5. Radical SAM mechanism: No CxxxCxxC motif for [4Fe-4S] cluster; wrong fold entirely

Could the Cysteines Function Differently Than Expected?

While individual cysteines can serve structural roles (zinc coordination, disulfide stabilization) or regulatory roles (redox sensing), none of these constitute "oxidoreductase activity" as defined by GO:0016491. The C-terminal Cys107 has low pLDDT (63.5), suggesting it is flexible/disordered rather than structurally important.

Could MJ1511 Be a Decarboxylase Instead?

Gamma-carboxymuconolactone decarboxylases (PcaC-type) share the CMD fold but catalyze a different reaction. However, M. jannaschii is a methanogenic archaeon that lives in deep-sea hydrothermal vents — an environment where aromatic compound degradation via the beta-ketoadipate pathway is not expected. PcaC enzymes are found in soil bacteria and fungi that degrade plant-derived aromatics. No evidence supports a decarboxylase role for MJ1511.

Paralog Confusion

MJ0742 is in the same PANTHER family and has the same annotations, but it resides in the oxidative stress gene cluster (adjacent to rubrerythrin, rubredoxin, AhpC). Its genomic context is more suggestive of a role in oxidative stress response than MJ1511's context. However, even MJ0742 lacks catalytic residues for oxidoreductase activity — it may serve a non-catalytic role (scaffolding, regulation) within that cluster.

Limitations and Knowledge Gaps

Limitations

1. No experimental validation: All conclusions are based on sequence analysis, structural prediction (AlphaFold), and literature analogy. No direct biochemical assay of MJ1511 has been performed. While the structural evidence strongly argues against oxidoreductase activity, a definitive negative requires biochemical testing.

2. AlphaFold model limitations: The AlphaFold structure (AF-Q58906-F1) has high overall confidence (pLDDT 93.8) but the C-terminal Cys107 region has lower confidence (pLDDT 63.5). The 36.52 Angstrom cysteine separation is robust given the high confidence of Cys17's region, but conformational dynamics are not captured by a single static model.

3. Absence of evidence is not evidence of absence: The lack of published studies on MJ1511 means we cannot rule out functions that have simply never been tested. M. jannaschii is a difficult organism to work with (obligate anaerobe, hyperthermophile), which limits available experimental data.

4. Pseudoenzyme classification is provisional: Calling MJ1511 a "pseudoenzyme" implies it once had enzymatic activity and lost it. The evolutionary trajectory is not established — it is possible that MJ1511 diverged from a common CMD ancestor before oxidoreductase activity evolved in the AhpD lineage.

5. Cross-organism extrapolation: The catalytic mechanism is defined from M. tuberculosis AhpD. While the CXXC + His requirement is conserved across all characterized AhpD-type enzymes, there is a formal possibility that an archaeal enzyme could use a completely novel mechanism within the same fold. This is considered highly unlikely given the complete absence of any recognizable catalytic residues.

Knowledge Gaps

Proposed Follow-up Experiments / Discriminating Tests

Highest-Priority Experiments

1. Oxidoreductase activity assay for recombinant MJ1511: Express and purify MJ1511 from E. coli; test for thiol-disulfide oxidoreductase activity using insulin reduction assay or DTNB-coupled AhpC reduction assay at 85 degrees Celsius. This is the most direct test — a negative result would definitively confirm pseudoenzyme status; a positive result (however unlikely) would overturn the structural analysis.

2. Cys→Ser mutagenesis: Mutate Cys17 and/or Cys107 to serine; test whether the protein retains any measurable activity or binding function. If wild-type shows no oxidoreductase activity, this experiment becomes moot — but if unexpected activity is found, mutagenesis identifies which cysteine(s) are involved.

3. Pull-down / co-immunoprecipitation: Express tagged MJ1511 in M. jannaschii or a related methanogen; identify binding partners by mass spectrometry. This would reveal non-catalytic functions.

4. Proteomics / transcriptomics under stress: Determine whether MJ1511 is expressed and whether its expression changes under oxidative stress, heat shock, or other conditions. If MJ1511 is not upregulated by oxidative stress but is upregulated by other stresses, this would point toward a non-oxidoreductase function.

Computational Analyses

1. Foldseek/DALI search against all PDB structures: Identify structural neighbors beyond the CMD family that might suggest alternative functions.

2. Coevolution analysis (EVcouplings/AlphaFold2-multimer): Predict whether MJ1511 forms specific protein-protein interactions, and with which partners.

3. PANTHER family review: Systematically flag all CMD family members in PANTHER that lack CXXC motifs, and recommend review of their oxidoreductase annotations.

Curation Leads

Lead 1: Remove GO:0016491 (Oxidoreductase Activity) from MJ1511

• Current annotation: GO:0016491, IBA, from PANTHER PTHR33930 via P9WQB5
• Recommended action: REMOVE
• Evidence level: Strong structural/evolutionary evidence against; no evidence for
• Key references:
• PMID: 12761216: "AhpD, a protein with two cysteine residues, is required for physiological reduction of the Mycobacterium tuberculosis alkylhydroperoxidase AhpC" — establishes the CXXC requirement
• PMID: 11914371: "The structure supports a mechanism... in which Cys-133 is deprotonated by a distant glutamic acid via the relay action of His-137 and a water molecule" — defines the His-dependent proton relay absent in MJ1511
• PMID: 16597838: "TTHA0727 is a distinct protein from alkylhydroperoxidase AhpD and gamma-carboxymuconolactone decarboxylase in the CMD family" — precedent for non-catalytic CMD proteins

Lead 2: Remove GO:0051920 (Peroxiredoxin Activity) from MJ1511

• Current annotation: GO:0051920, IEA
• Recommended action: REMOVE
• Rationale: More specific child term of GO:0016491; even less justified given absence of Prx catalytic Cys

Lead 3: Flag MJ0742 for Identical Curation Action

• Current annotation: GO:0016491 (IBA), GO:0051920 (IEA) — same as MJ1511
• Evidence: PDB 3D7I (1.75 Angstrom) shows 1 Cys, 0 His, no CXXC; no published oxidoreductase activity
• Recommended action: REMOVE both annotations; same rationale as MJ1511

Lead 4: Consider PANTHER Family-Level Review

• Family: PTHR33930 ("ALKYL HYDROPEROXIDE REDUCTASE AHPD")
• Issue: Propagates oxidoreductase activity to CMD members that lack CXXC catalytic motif
• Scope: At minimum 4 archaeal CMD proteins (MJ1511, MJ0742, and 2 others) are affected; likely more
• Recommended action: Review all family members for CXXC motif presence before propagating GO:0016491

Lead 5: Consider Adding "CMD Domain-Containing Protein" Annotation

• Proposed annotation: InterPro IPR002526 (CMD domain); no GO molecular function until experimental evidence is available
• Justification: The fold is confidently predicted (pLDDT 93.8) and the CMD domain is clearly present; only the function is in question

Evidence Base: Key Literature

Artifacts

• OpenScientist final report
• OpenScientist final report
• OpenScientist mj1511 analysis
  
• OpenScientist mj1511 comprehensive evidence
  
• OpenScientist mj1511 final summary
  
• OpenScientist plot 1
  
• OpenScientist plot 2
  
• OpenScientist plot 3